Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMT injection for lymphatic mapping in thyroid cancer surgery
CTR20171137Phase 3Completed
- Sponsor
- Shenyang Pharmaceutical University
- Start
- Jun 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of MMT in thyroid cancer, sponsored by Shenyang Pharmaceutical University. Started Jun 2018; status: completed.
02
Drugs
MMT
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on CTR20171137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171137.